NASDAQ : PACB

Pacific Biosciences of California, Inc. — Company profile

Healthcare · Medical Devices · United States

Last price 2.455 USD (Oct 30, 2026, 2:42 PM EDT) · Market cap 763.09M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, the company provides Revio, Vega, and Sequel instruments which conduct, monitor, and analyze single-molecule biochemical reactions on SMRT cell microchips; short-read sequencing; and onso instrument. It serves academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations, pharmaceutical companies, and agricultural companies. The company markets its products through a sales force and distribution partners in Australia, certain parts of Asia, Europe, the Middle East, Africa, Central America, and South America. It has a collaboration with DNAstack Inc. to provide federated dataset of HiFi whole genome sequencing data. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Details

NamePacific Biosciences of California, Inc.
SectorHealthcare
IndustryMedical Devices
Employees485
Founded2000
Ipo Date2010-10-27
CeoMark Van Oene
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS69404D1081
Cusip69404D108
Cik0001299130
Sic3826
Stock TypeCommon Stock

Key executives

NameTitle
Mark Van Oene Ph.D.Chief Executive Officer, President and Director
James R. Gibson IIChief Financial Officer and Principal Accounting Officer
Christian O. Henry M.B.A.Senior Business Advisor and Director
Dr. Stephen Turner Ph.D.Co-Founder
Dr. Brett Atkins J.D., Ph.D.General Counsel and Corporate Secretary
Natalie WelchChief People Officer

Contact

Address1305 O’Brien Drive, Menlo Park, California 94025, United States
Phone650 521 8000
Websitehttps://www.pacb.com